Lifecore Biomedical
LFCR
108 hedge funds and large institutions have $355M invested in Lifecore Biomedical in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 6 closing their positions.
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
9% more funds holding
Funds holding: 99 → 108 (+9)
4% more capital invested
Capital invested by funds: $342M → $355M (+$13.8M)
17% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 36
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$6.21M |
| 2 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$3.14M |
| 3 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$2.91M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$2.55M |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$1.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$8.86M |
| 2 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
-$5.38M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
-$4.92M |
| 4 |
Morgan Stanley
New York
|
-$2.39M |
| 5 |
KG
Killen Group
Berwyn,
Pennsylvania
|
-$971K |
LFCR Hedge Fund Activity: Q2 2015 in Review
108 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q2 2015, worth a combined $355M — up 4% from $342M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new LFCR positions and 6 closed out — a net gain of 9 holders — while 30 added to existing stakes and 36 trimmed.
The largest buyer was Heartland Advisors, adding an estimated $6.21M. The largest seller was Guggenheim Capital, cutting an estimated $8.86M.
- 108 institutional investors held Lifecore Biomedical (LFCR) as of Q2 2015, up from 99 in Q1 2015.
- Funds reported $355M of Lifecore Biomedical stock for Q2 2015, up 4% quarter-over-quarter.
- 15 funds opened new Lifecore Biomedical positions in Q2 2015 and 6 closed out, a net change of +9 holders.
- The largest Lifecore Biomedical buyer in Q2 2015 was Heartland Advisors, an estimated $6.21M added.
- The largest Lifecore Biomedical seller in Q2 2015 was Guggenheim Capital, an estimated $8.86M sold.
Based on aggregated 13F filings for Q2 2015.